Core Prescribing Solutions

Core Prescribing Solutions Core Prescribing Solutions (CPS) is a dynamic healthcare organization providing tailor-made primary

Core Prescribing Solutions is a dynamic healthcare organisation that has amassed over 20 years worth of combined experience within the NHS, primary care, health informatics and pharmacy sector. Core Prescribing Solutions provides tailor-made primary care packages through a fully managed pharmacist or technician-led model suited to the needs of GP practices and clients in order to reduce workload pressures and streamlining inefficiencies.

A pharmacist isn’t automatically a clinical pharmacist.The difference isn’t the job title.It’s scope, supervision and pa...
10/03/2026

A pharmacist isn’t automatically a clinical pharmacist.

The difference isn’t the job title.
It’s scope, supervision and patient-facing responsibility.

In primary care, that distinction matters.

When roles are clearly defined:

• Medicines reviews are structured
• Clinical decisions sit with the right level of oversight
• Governance becomes visible
• Prescribing risk is easier to manage

When roles blur, accountability drifts.

And when accountability drifts, governance weakens.

Clear role design doesn’t add bureaucracy.
It protects both patients and practices.

🔗 Clinical Pharmacist vs Pharmacist – read more:
https://bit.ly/4lrUYea

09/03/2026

Medication safety alerts reveal something important about clinical pharmacy in general practice.

When updates are issued by the Medicines and Healthcare products Regulatory Agency (MHRA) - whether for established medicines like topiramate or newer therapies such as semaglutide - the real work of implementation happens in primary care.

Safety guidance only improves outcomes when it is translated into day-to-day clinical practice.

That usually means structured medicines work across PCNs and practices:

• Running patient cohort searches
• Calling patients in for structured reviews
• Explaining updated safety advice
• Adjusting treatment plans where appropriate

These are the moments where PCN-based pharmacists demonstrate their value - turning national safety guidance into safe, practical changes in patient care.

Medication safety doesn’t improve through alerts alone.
It improves when practices have the systems and clinical capacity to act on them.

💬 For those working in PCNs or general practice - which recent medication safety alert created the biggest review project in your setting?

09/03/2026

We’re proud to share that Core Prescribing Solutions has achieved Great Place To Work Certification™️.

This recognition is particularly meaningful because it is based entirely on anonymous feedback from our team about their experience working here.

At Core Prescribing Solutions, our people are at the heart of everything we do. From our Clinical Pharmacists and Pharmacy Technicians to our senior leadership team, everyone plays an important role in supporting GP practices, Primary Care Networks and GP federations nationally.

Creating a supportive, collaborative environment helps our teams deliver the high-quality clinical pharmacy services that improve medicines optimisation and patient outcomes in primary care.

We’re incredibly grateful to our colleagues for the work they do every day and for helping us build a culture we can all be proud of.

You can read more about the certification here:
🔗 https://bit.ly/47sWGWz

Reactive recruitment is expensive.Predictive workforce planning is strategic.Vacancies rarely appear overnight.They buil...
06/03/2026

Reactive recruitment is expensive.
Predictive workforce planning is strategic.

Vacancies rarely appear overnight.
They build quietly - as demand rises, complexity increases and skill mix drifts.

The strongest systems don’t wait for pressure to escalate.
They model demand, align skill mix early, and design capacity around predictable workload.

Primary care is no different.

When medicines delivery is forecasted properly:
• Recruitment becomes proactive
• Supervision capacity is planned
• Governance remains stable
• GP time isn’t lost to reactive fixes

Workforce planning isn’t corporate theory.
It’s operational risk management.

🔗 Predictive Workforce Planning – read more: https://bit.ly/3N8KMKL

04/03/2026

Medicines optimisation doesn’t improve because guidance exists.
It improves when ownership is explicit.

Policies don’t change outcomes.
Workflow does.

When clinical pharmacists lead structured medicines reviews:

• Risk surfaces earlier
• Polypharmacy becomes visible
• Monitoring becomes predictable
• QOF performance stabilises

The difference isn’t the presence of expertise.
It’s whether that expertise has a clear, governed role within the system.

Medicines optimisation becomes reliable when it has a named owner, structured review cadence, and visible outcomes.

🔗 The Role of Clinical Pharmacists in Medicines Optimisation – read more: https://bit.ly/4cruN4S

04/03/2026

Obesity management isn’t a campaign. It’s a medicines system.

It sits at the intersection of:

• Type 2 diabetes
• Hypertension
• Cardiovascular risk
• Polypharmacy

Which means it also intersects with QOF stability.

World Obesity Day is a useful reminder that metabolic optimisation rarely improves through awareness alone.

It improves when systems are designed to support it.

In practice, that means:

• Clear LTC ownership
• Structured medication reviews rather than opportunistic checks
• Medicines optimisation embedded into routine workflow
• Predictable follow-up and monitoring

Without that structure, outcomes rarely collapse overnight.

They drift quietly across multiple conditions.

💬 Who owns metabolic optimisation in your Practice or PCN today?

03/03/2026

We’re proud to be nominated for Primary Care Provider of the Year at the HealthInvestor Awards 2026.

Recognition matters - but what matters more is why.

Primary care continues to operate under sustained pressure.
Workload is rising.
Governance expectations are increasing.
Delivery models are evolving.

Our focus has always been clear:

Design medicines systems that are structured, measurable and safe.

Across the PCNs and practices we support, that means:

• Clear clinical ownership
• Structured medication reviews
• Defined supervision and governance
• Measurable outcomes - not just activity

This nomination reflects the work of our clinical teams, operational leads and partner practices who are committed to strengthening medicines delivery in primary care.

We’d also like to wish the very best of luck to all the other nominees on the night. The standard across the sector is strong, and it’s encouraging to see primary care innovation recognised.

Whatever the outcome, our focus remains the same:

Predictable delivery.
Stronger governance.
Better patient outcomes.

03/03/2026

The role of SGLT2 inhibitors in Chronic Kidney Disease is no longer secondary. It is structural.

Evidence now demonstrates significant renal protection and cardiovascular benefit, even beyond glycaemic control. For many patients with CKD, SGLT2 inhibitors are becoming a core component of disease modification, not an add-on.

That shift has operational consequences.

For practices and PCNs, it creates the need to:

• Proactively identify eligible CKD cohorts
• Review treatment pathways in line with updated NICE guidance
• Initiate therapy earlier where appropriate
• Align optimisation work with CKD-related QOF indicators

This is not just a prescribing update.
It is a register management and workflow question.

Early identification and timely initiation depend on:

• Structured population searches
• Protected medication review clinics
• Clear clinical ownership
• Defined monitoring and follow-up pathways

Without structure, eligible patients are missed.
With structure, progression risk can be reduced and unplanned admissions potentially mitigated.

Improving renal outcomes is not simply about hitting QOF points.
It is about slowing decline and protecting long-term quality of life.

If your practice is planning its CKD optimisation work this year, we’d be happy to work together.

🔗 https://bit.ly/42WodxG

02/03/2026

March doesn’t create QOF pressure. It reveals it.

When performance feels unstable at year end, it’s rarely about effort.

It’s usually about:

• Medicines work without clear ownership
• Reviews that weren’t structured early
• Monitoring that became reactive
• Workflow that tightened under demand

QOF rarely slips suddenly.
It drifts quietly - then March exposes it.

The most stable practices don’t work harder at year end.
They design clarity into ownership and review cadence from the start.

💬 Where does QOF feel most fragile in your setting right now?

02/03/2026

The recent update to NICE guidance on Type 2 Diabetes changes more than prescribing order. It changes pathway design.

The move of SGLT2 inhibitors from second-line to first-line treatment for many patients reflects growing evidence of cardiovascular and renal benefit, not just glycaemic control.

That shift has operational consequences.

It means:

• Reviewing existing treatment pathways
• Identifying eligible patients systematically
• Aligning prescribing with current guidance
• Ensuring monitoring and follow-up are structured

Guidance alone does not change outcomes.
Workflow does.

For PCNs, this is not just a clinical update.
It is a medicines optimisation and LTC ownership question.

How clearly is metabolic optimisation structured in your team today?

🔗 NICE guidance overview: https://bit.ly/4r2ZNeU

27/02/2026

February had one clear theme.

When medicines ownership is explicit, outcomes become predictable.

Across primary care, the strongest systems weren’t the busiest.
They were the most structured.

Clear scope.
Defined supervision.
Repeatable workflows.
Measurable outcomes.

March is where ARRS planning becomes real for many PCNs.

Next week, we’ll share a practical delivery model that shows what “good” looks like in action.

26/02/2026

At Best Practice today? Come and find G42

Final day.

If you want a practical conversation about improving pharmacy delivery in your PCN, come and see us.

We’re sharing real-world examples of:

•⁠ ⁠What works
•⁠ ⁠What doesn’t
•⁠ ⁠What PCNs often underestimate
•⁠ ⁠Where the quick wins actually are

Stand G42.

We’re here until close.

Address

Third Floor, Refuge Buildings, 9-11 Sunbridge Road
Bradford
BD12AZ

Opening Hours

Monday 9am - 6pm
Tuesday 9am - 6pm
Wednesday 9am - 6pm
Thursday 9am - 6pm
Friday 9am - 6pm
Saturday 9am - 1:30pm

Website

Alerts

Be the first to know and let us send you an email when Core Prescribing Solutions posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Core Prescribing Solutions:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category